Veracyte traded at $20.57 this Friday July 1st, increasing $0.67 or 3.37 percent since the previous trading session. Looking back, over the last four weeks, Veracyte gained 12.84 percent. Over the last 12 months, its price fell by 47.92 percent. Looking ahead, we forecast Veracyte to be priced at 22.13 by the end of this quarter and at 20.39 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
20.57
Daily Change
3.37%
Yearly
-47.92%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agilent 117.90 -0.87 -0.73% -20.78%
Agenus 1.89 -0.06 -2.84% -65.85%
Anika Therapeutics 22.47 0.15 0.67% -49.47%
Arrowhead Research 36.03 0.82 2.33% -57.59%
Biocept 0.96 0.02 2.45% -77.81%
Bruker 62.67 -0.09 -0.14% -18.10%
Exact Sciences 40.80 1.41 3.57% -66.78%
Heron Therapeutics 2.78 -0.02 -0.54% -81.34%
Illumina 187.32 2.96 1.61% -60.54%
Immunogen 4.57 0.07 1.56% -28.93%
Karyopharm Therapeutics 4.65 0.14 3.10% -55.76%
Ligand Pharmaceuticals 89.21 -0.01 -0.01% -33.05%
Laboratory Of America 237.86 3.50 1.49% -14.42%
Myriad Genetics 18.44 0.27 1.49% -41.09%
Rigel Pharmaceuticals 1.17 0.04 3.10% -73.58%
Roche Holding 319.50 0.95 0.30% -8.60%
Sangamo BioSciences 4.19 0.05 1.21% -64.22%
Sonic Healthcare 32.94 -0.07 -0.21% -13.45%
Siemens 96.00 -1.09 -1.12% -28.28%
Thermo Fisher Scientific 539.23 -4.05 -0.75% 5.05%
Veracyte 20.57 0.67 3.37% -47.92%
Waters 332.05 1.07 0.32% -6.59%
Intrexon 1.38 0.04 2.91% -78.52%

Indexes Price Day Year
USND 10999 -29.50 -0.27% -24.87%
US2000 1705 -3.20 -0.19% -26.06%

Veracyte
Veracyte, Inc. is a genomic diagnostics company. The Company, through its scientific platform, which utilizes ribonucleic acid (RNA), whole-transcriptome sequencing combined with machine learning, produces genomic tests. It provides various genomic tests, including Afirma Genomic Sequencing Classifier (GSC), Percepta Bronchial Genomic Classifier, Envisia Genomic Classifier and Afirma Xpression Atlas. It provides GSC tests for thyroid cancer. It provides Percepta Bronchial Genomic Classifier tests for lung cancer. It provides Envisia Genomic Classifier tests for idiopathic pulmonary fibrosis (IPF). Its Afirma Xpression Atlas provides information on gene alterations associated with thyroid cancer, enabling physicians to tailor surgical and treatment decisions at time of diagnosis.